Why is endosonography insufficient for residual diagnosis after neoadjuvant therapy for esophageal cancer? Solutions using muscle layer evaluation

Autor: Shohei Yonemoto, Masaya Uesato, Akira Nakano, Kentaro Murakami, Takeshi Toyozumi, Tetsuro Maruyama, Hiroshi Suito, Tomohide Tamachi, Manami Kato, Shunsuke Kainuma, Keisuke Matsusaka, Hisahiro Matsubara
Rok vydání: 2021
Zdroj: World journal of gastrointestinal endoscopy. 14(5)
ISSN: 1948-5190
Popis: The diagnosis of residual tumors using endoscopic ultrasound (EUS) after neoadjuvant therapy for esophageal cancer is considered challenging. However, the reasons for this difficulty are not well understood.To investigate the ultrasound imaging features of residual tumors and identify the limitations and potential of EUS.This exploratory prospective observational study enrolled 23 esophageal squamous cell carcinoma patients receiving esophagectomy after neoadjuvant therapy [15 patients after neoadjuvant chemotherapy (NAC) and 8 patients after chemoradiotherapy (CRT)] at the Department of Surgery, Chiba University Hospital, between May 2020 and October 2021. We diagnosed the T stage for specimens using ultrasound just after surgery and compared ultrasound images with the cut surface of the fixed specimens of the same level of residual tumor. The ratio of esophageal muscle layer defect measured by ultrasound was compared with clinicopathological factors. Furthermore, the rate of reduction for the muscle layer defect was evaluated using EUS images obtained before and after neoadjuvant therapy.The accuracy of T stage rate was 61% (Compared to pathological images, some tumors are undetectable by ultrasound. Focusing on the esophageal muscle layer might help diagnose the depth of the residual tumor.
Databáze: OpenAIRE